Inizia
BADQOMOCAWGOWLD

$ATXI entry 1.35-1.45 Target PT 5-7-11 and higher

Long
Avenue Therapeutics, Inc. (NASDAQ:ATXI)  
BADQOMOCAWGOWLD  
NASDAQ:ATXI   Avenue Therapeutics, Inc.
Beyond Technical Analysis Wave Analysis Technical Indicators Divergence Bullish Patterns signal signals strength target
2
0
beyondta waveanalysis indicator divergence bullish signal signals strength target
Avenue Therapeutics, Inc., a specialty pharmaceutical company, acquires, licenses, develops, and commercializes products primarily for use in the acute/intensive care hospital setting. Its product candidate is intravenous Tramadol, which is in Phase III clinical trials to treat moderate to moderately severe post-operative pain. The company was incorporated in 2015 and is based in New York, New York.
Declinazione di responsabilità

Le informazioni ed i contenuti pubblicati non costituiscono in alcun modo una sollecitazione ad investire o ad operare nei mercati finanziari. Non sono inoltre fornite o supportate da TradingView. Maggiori dettagli nelle Condizioni d'uso.